Answers are grounded in this paper and cite their sources.
Cyanobacteria respond to environmental stress through coordinated metabolic and extracellular adaptations, yet the relationship between intracellular metabolism and extracellular polymeric substance (EPS) remodeling remains poorly understood. In this study, we investigated the effects of optimal ampicillin and nanoscale zero-valent iron nanoparticles (nZVIs) applied individually or in combination on cellular metabolism and EPS fractionation in the model cyanobacterium Fremyella diplosiphon cultivated under scale-up bioreactor conditions. Ampicillin enhanced chlorophyll a and phycocyanin autofluorescence, ATP luminescence , and lactate accumulation, indicating increased metabolic activity under antibiotic stress. In contrast, nZVI treatment produced the highest ATP levels without a corresponding increase in lactate, suggesting a shift in cellular energy metabolism. The combined treatment produced intermediate ATP levels, while lactate remained comparable to the control. In addition, distinct treatment-specific effects were observed in volumetric EPS accumulation (mg/L). Ampicillin resulted in the highest LB-EPS accumulation, whereas all treatments significantly increased TB-EPS accumulation relative to the control, with no significant differences among the treated groups. The combined treatment resulted in the highest S-EPS accumulation. Soluble EPS protein levels were higher under individual ampicillin and nZVI treatments than the combined treatment , while tightly bound EPS protein was highest in the combined treatment, demonstrating differential extracellular matrix remodeling. Our findings reveal that antibiotic and nanoparticle stressors differentially regulate intracellular metabolism and volumetric EPS accumulation during large-scale cultivation, highlighting coordinated adaptive mechanisms that contribute to cyanobacterial resilience. This integrated adaptive response provides new insights into stress-induced physiological plasticity in cyanobacteria and offers a foundation for optimizing nanoparticle–antibiotic interactions in scalable biotechnological applications.
No takes yet. Share an insight, caveat, or question.
Yalcin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: